These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 21799409)

  • 1. Inflammatory myopathies: management of steroid resistance.
    Dalakas MC
    Curr Opin Neurol; 2011 Oct; 24(5):457-62. PubMed ID: 21799409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic approaches in patients with inflammatory myopathies.
    Dalakas MC
    Semin Neurol; 2003 Jun; 23(2):199-206. PubMed ID: 12894385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic options in autoimmune inflammatory myopathies (dermatomyositis, polymyositis, inclusion body myositis).
    Pongratz D
    J Neurol; 2006 Sep; 253 Suppl 5():V64-5. PubMed ID: 16998756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic strategy in inflammatory myopathies (polymyositis, dermatomyositis, overlap myositis, and immune-mediated necrotizing myopathy)].
    Tournadre A
    Rev Med Interne; 2014 Jul; 35(7):466-71. PubMed ID: 24144868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of idiopathic inflammatory myopathies.
    Amato AA; Griggs RC
    Curr Opin Neurol; 2003 Oct; 16(5):569-75. PubMed ID: 14501840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy of myositis: issues, concerns and future prospects.
    Dalakas MC
    Nat Rev Rheumatol; 2010 Mar; 6(3):129-37. PubMed ID: 20125096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy of inflammatory myopathies: practical approach and future prospects.
    Dalakas MC
    Curr Treat Options Neurol; 2011 Jun; 13(3):311-23. PubMed ID: 21365201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic advances in myositis.
    Aggarwal R; Oddis CV
    Curr Opin Rheumatol; 2012 Nov; 24(6):635-41. PubMed ID: 22955021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intravenous immunoglobulins in the treatment of polymyositis and dermatomyositis].
    Cherin P
    Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S48-50. PubMed ID: 10896990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of polymyositis and dermatomyositis.
    Kaye SA; Isenberg DA
    Br J Hosp Med; 1994 Nov 2-15; 52(9):463-8. PubMed ID: 7874361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current treatment of the inflammatory myopathies.
    Dalakas MC
    Curr Opin Rheumatol; 1994 Nov; 6(6):595-601. PubMed ID: 7865379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of the inflammatory myopathies: update and practical recommendations.
    Hengstman GJ; van den Hoogen FH; van Engelen BG
    Expert Opin Pharmacother; 2009 May; 10(7):1183-90. PubMed ID: 19405792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dysimmune and inflammatory myopathies].
    Authier FJ
    Rev Prat; 2008 Dec; 58(20):2253-60. PubMed ID: 19209656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic advances and future prospects in immune-mediated inflammatory myopathies.
    Dalakas MC
    Ther Adv Neurol Disord; 2008 Nov; 1(3):157-66. PubMed ID: 21180574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory myopathies: how to treat the difficult cases.
    Mastaglia FL; Zilko PJ
    J Clin Neurosci; 2003 Jan; 10(1):99-101. PubMed ID: 12464534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory myopathies: clinical, diagnostic and therapeutic aspects.
    Mastaglia FL; Garlepp MJ; Phillips BA; Zilko PJ
    Muscle Nerve; 2003 Apr; 27(4):407-25. PubMed ID: 12661042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic strategies in idiopatic inflammatory myopathies].
    Chakour R; Leimgruber A; Bart PA; Spertini F
    Rev Med Suisse; 2009 Apr; 5(199):812-8. PubMed ID: 19441746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose intravenous immunoglobulin in inflammatory myopathies: experience based on controlled clinical trials.
    Dalakas MC
    Neurol Sci; 2003 Oct; 24 Suppl 4():S256-9. PubMed ID: 14598055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous gamma globulin as first line therapy in polymyositis and dermatomyositis: an open study in 11 adult patients.
    Cherin P; Piette JC; Wechsler B; Bletry O; Ziza JM; Laraki R; Godeau P; Herson S
    J Rheumatol; 1994 Jun; 21(6):1092-7. PubMed ID: 7932419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.